Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

This clinical-stage biotech develops antibody therapies for cancer and infectious diseases, leveraging proprietary discovery ...

A new year means a new Fierce Biotech Fundraising Tracker to record the significant amounts of venture capital being funneled into the industry. We're maintaining the criteria we used for last year's ...

Performance data quoted represents past performance, which does not guarantee future results. Current performance may be lower or higher than the figures shown. Principal value and investment returns ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

In this article, we will look at the 12 Cheap Biotech Stocks to Buy Now.

In this article, we will be taking a look at the 11 Cheap Biotech Stocks to Buy According to Hedge Funds. Mizuho’s Jared Holz appeared on CNBC’s “Closing Bell Overtime” on July 8 to talk about whether ...

Allison DeAngelis is the East Coast biotech and venture capital reporter at STAT, reporting where scientific ideas and money meet. She is also co-host of the weekly biotech podcast, The Readout Loud.

Performance data quoted represents past performance, which does not guarantee future results. Current performance may be lower or higher than the figures shown. Principal value and investment returns ...

NASDAQ: ABVX: $68 million (14.9% of AUM) NASDAQ: AMLX: $62.6 million (13.7% of AUM) NASDAQ: JAZZ: $39.6 million (8.7% of AUM) NASDAQ: DYN: $33.8 million (7.4% of AUM) NASDAQ: COGT: $29.1 million (6.4% ...

Scholar Rock develops therapies for neuromuscular and oncological diseases, leveraging a proprietary platform to target unmet medical needs.